Dublin, May 08, 2018 -- The "Point-of-Care Diagnostics & Biosensors Europe 2018" conference has been added to ResearchAndMarkets.com's offering.
Point-of-Care Diagnostics Europe 2018 brings together the key opinion leaders from both academia and industry, this annual conference will discuss the expanding Point-of-Care Diagnostics and Global Health fields and provide the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.
This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval. Experts in these fields will share their views on point-of-care in the clinical setting. The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations. Also, we frame the role of POC testing in the expanding Global Health field and highlight opportunities existing in many parts of the world.
This conference covers POC Detection, POC Diagnostics and POC-based Treatment Options as part of the Comprehensive Coverage of this Expanding Field. The POC testing field is expanding focused not only on infectious disease diagnostics (which represents 80% of the marketplace) but also with cancer and cardiovascular disease focus. We address each of these segments in this conference.
Agenda:
- Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
- Low Cost POC Diagnostics Platforms for Deployment Worldwide
- POC Diagnostics for Global Health: A Worldwide Perspective
- POC Diagnostics in Cardiovascular Disease Testing
- Point-of-Care Diagnostics in Infectious Disease Testing
- Wearable and Implantable Devices
- Worldwide Regulatory Trends and Hurdles in the Deployment of POC Testing
For more information about this conference visit https://www.researchandmarkets.com/research/nqcksd/european?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology, Point-of-Care Diagnostics


Microsoft Gaming Leadership Overhaul: Phil Spencer Retires, Asha Sharma Named New Xbox CEO
HSBC Cuts 10% of U.S. Debt Capital Markets Team Amid Ongoing Business Revamp
Nvidia Earnings Preview: AI Growth Outlook Remains Strong Beyond 2026
Bill Gates Pulls Out of India’s AI Impact Summit Amid Controversy and Event Mismanagement
Vietnam Airlines, Vietjet, and Sun PhuQuoc Airways Sign Major Boeing Aircraft Deals Amid U.S.–Vietnam Trade Talks
FERC Approves Blackstone Infrastructure’s Acquisition of TXNM Energy, Advancing Utility Merger
Moncler Shares Surge on Strong Q4 Revenue Growth and Robust China Demand
OpenAI Targets $600B Compute Spend as IPO Valuation Could Reach $1 Trillion
Mark Zuckerberg Testifies in Youth Social Media Addiction Trial Over Instagram Policies
Texas Attorney General Ken Paxton Sues Sanofi Over Alleged Healthcare Bribery Scheme
Alibaba, Baidu, BYD Shares Slide After Pentagon Military List Update
Boeing Secures 50 737 MAX Jet Order from Vietnam Airlines Amid Expanding Global Demand
Nvidia Nears $30 Billion Investment in OpenAI, Replacing Previous $100 Billion AI Partnership 



